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Abstract 
Cytomegalovirus infections are widely distributed with a seroprevalence of up to 100%. The 
majority of the cases take a silent course or deal with unspecific clinical symptoms. Complica-
tions in immunocompetent patients are rare but may affect the liver and lead up to an acute 
organ failure. In this case report, we describe a 35-year-old immunocompetent female with 
an acute cytomegalovirus infection presenting as acute hepatitis with ongoing upper right 
abdominal pain after cholecystectomy. Upper right abdominal pain is a common symptom 
with a wide range of differential diagnoses. If common reasons can be excluded, we want to 
sensitize for cytomegalovirus infection as a minor differential diagnosis even in immuno-
competent patients. © 2015 The Author(s) 
 Published by S. Karger AG, Basel 
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Background 
Cytomegalovirus (CMV) infections have a worldwide impact due to the high congenital 
infection rates, disease burden and associated costs. More accurately, this virus is called the 
human herpesvirus type 5. It has a seroprevalence of 30–100% depending on the age, eth-
nicity as well as social and immune status of the study group [1–3]. Transmission occurs via 
secretions like tears, saliva, urine, genital secretions, breast milk or blood. The incubation 
time is 4–6 weeks. Afterwards, the virus may remain clinically silent or appear with unspe-
cific symptoms like fatigue, cough or fever in immunocompetent patients [4]. By contrast, 
infections may result in severe disease and failure of several organs in patients with a con-
genital or acquired immunodeficiency, e.g. due to HIV, the infantile immune system of new-
borns or under immunosuppressive therapy. The drugs of choice for treatment of CMV infec-
tions in immunosuppressed hosts are ganciclovir and valganciclovir for a less severe disease 
[5]. Upper right abdominal pain is one of the major symptoms when the liver is affected and 
is associated with elevated liver enzymes [4]. The severity may vary from mild elevated en-
zymes to acute liver failure [6]. In this case report, we present the case of a female patient 
with upper right abdominal pain and gallstones. After a cholecystectomy she had no pain 
relief, leading to an extensive investigation cascade resulting in this rare diagnosis.  
Case Presentation 
A 35-year-old obese female patient of Eritrean origin presented as an outpatient with 
epigastralgia and vomiting for 2 months. An ultrasound of the abdomen showed gallstones 
without a sign for inflammation. Therefore, she was scheduled for laparoscopic cholecystec-
tomy. Her previous history showed lower back pain and a gluteal lipoma. The surgical pro-
cedure was performed without complications. The histological workup showed a gall blad-
der with signs of cholesteatosis. The patient was discharged on the second postoperative 
day.  
One week later she presented to the emergency department with ongoing pain in the 
upper right abdomen. The postoperative ultrasound was normal, and we found slightly ele-
vated liver enzymes with alanine transaminase (ALT) 101 U/l, aspartate transaminase (AST) 
123 U/l and gamma-glutamyl transpeptidase (GGT) 128 U/l. She was prescribed pain medi-
cation and was scheduled for a follow-up visit the next day. The laboratory test of the next 
day showed a strong increase of the liver enzymes with ALT 1,521 U/l, AST 1,336 U/l and 
GGT 618 U/l (fig. 1). She complained of undiminished pain in spite of pain medication. In 
order to look for an abscess or an acute ischemia of the liver, the patient was hospitalized 
and a computed tomography (CT) of the abdomen was performed. After inconspicuous re-
sults of the CT, a magnetic resonance Cholangiopancreatography was performed addressing 
the question of pathology of the biliary duct system. It did not show any pathological result. 
With the working diagnosis of a cholangitis with increasing liver enzymes, infectious param-
eters with C-reactive protein (CRP) 267 mg/l and leucocytes (LC) 15 × 109/l at their maxi-
mum and impaired coagulation with a spontaneous international normalized ratio of 1.2(fig. 
1, fig. 2, fig. 3), antibiotic therapy with amoxicillin/clavulanic acid was initiated. In absence of 
a clinical improvement and a further increase of the liver enzymes, a hepatitis serology was 
performed and showed seropositivity for a former hepatitis type A. The simultaneously per-
formed screening for EBV, HIV and CMV showed a former infection of EBV and an acute in-
fection of CMV. An antiviral medication was omitted due to its toxicity, and antibiotic thera-
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py was terminated. With clinical and laboratory recovery (CRP 51 mg/l; LC 8.1 × 109/l; AST 
29 U/l), the patient could be discharged on day 9 of the second in-patient stay.  
Discussion 
In this immunocompetent patient, we diagnosed an acute CMV infection with hepatitis 
by immunoassay testing. Following the guidelines, we did not install an antiviral therapy, 
which was not indicated in our case. In a patient presenting with highly elevated liver en-
zymes and parameters of cholestasis but without elevated bilirubin, one must think of hepa-
titis.  
Any patient with the appropriate risk profile should be tested for hepatitis A, B and C. If 
these serological tests do not confirm acute hepatitis, further serological profiles including 
HIV, EBV and CMV should be included. Retrospectively, the upper abdominal pain in our 
patient may have been based on the acute CMV infection and not due to the gallstones shown 
in the radiologic diagnostics. But at that time, the liver enzymes were not elevated, and 
symptomatic gallstones are very common and serological testing is time-consuming and 
expensive. Therefore, the cholecystectomy is still indicated, although in this case, the surgery 
may have aggravated the CMV infection. Postoperatively, surgical complications must be 
ruled out because they are more common in this setting. 
CMV is the most common reason for a congenital infection worldwide. It is also pre-
sumed to be a major cause of mortality in immunocompromised patients [5]. The gold 
standard to confirm the diagnosis is the presence of CMV-specific antibodies type IgG and 
IgM in the (maternal) blood sample running an immunoassay or a polymerase chain reac-
tion, which can be either qualitative or quantitative by measuring the amount of viral DNA in 
the respective sample[4, 5]. CMV disease typically presents as mild and self-limiting mono-
nucleosis syndrome without an organ complication [3]. Therefore, in immunocompetent 
individuals no treatment is needed. CMV diseases are more often complicated in HIV-
positive or other immunocompromised patients like those with organ transplantation, bone 
marrow transplantation, neutropenia due to chemotherapy or radiation therapy. Complica-
tions might manifest as retinitis, esophagitis, and enteritis. Other manifestations include 
peripheral neuropathy, polyradiculoneuritis, pneumonitis, gastritis, colitis, and hepatitis [5]. 
Hepatitis as a manifestation of CMV infection is a rare but known complication usually not 
needing antiviral therapy due to its self-limiting course. Antiviral treatment is reserved for 
severe CMV infections because of its potential side effects including myelosuppression, cen-
tral nervous system disorders, hepatotoxicity, irreversible infertility (inhibition of spermat-
ogenesis), or teratogenesis [7]. Indications for antiviral treatment are mostly based on the 
clinical course and on the polymerase chain reaction threshold. The cutoff varies from insti-
tution to institution but in general it is located around 10,000 viral copies/ml of blood [5]. 
When treatment is needed, it should be given for a minimum of 2–3 weeks. The end point of 
intravenous therapy is the documented clearance of virus from the blood. Regimens for 
adults should be adjusted for renal dysfunction (table 1). To avoid a relapse after intrave-
nous therapy, oral treatment with valganciclovir for 2–3 months may be performed in high-
risk patients (table 2) [8, 9]. 
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Conclusions 
With this case report, we want to raise the awareness for an unusual diagnosis: an acute 
CMV infection. If common reasons for upper right abdominal pain are ruled out, clinical 
symptoms are persistent, and liver enzymes are elevated, this diagnosis should be sought, 
regardless whether patients are immunocompetent or not.  
Statement of Ethics 
Written informed consent was obtained from the patient for publication of this case re-
port and the accompanying tables and figures. 
Disclosure Statement 
The authors declare that they have no competing interests. 
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Fig. 1. Chronological trend of liver enzymes during the postoperative course. 
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Fig. 2. Chronological trend of coagulation measured by international normalized ratio (INR) during the 
postoperative course. 
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Fig. 3. Chronological trend of infectious parameters given as CRP and LC during the postoperative course. 
 
Table 1. Dosing of intravenous ganciclovir for the treatment of CMV infection including dose modification 
for patients with impaired renal function [8] 
   
   
 Intravenous dose,  
mg/kg 
Frequency 
   
   
Serum creatinine   
<2.0 mg/dl 5 Q12h 
<2–3 mg/dl 5 Daily 
<3–5 mg/dl 1.25 Daily 
>5.0 mg/dl 1.25
a
 QOD 
Hemodialysis 5 Post-dialysis 
Peritoneal dialysis 2.5
a
 Daily 
   
   
Q12h = Every 12 h; QOD = every other day. 
a
 After a loading dose of 5 mg/kg i.v. 
 
 
 
 
D
ow
nl
oa
de
d 
by
: 
19
8.
14
3.
58
.1
 - 
2/
29
/2
01
6 
6:
13
:5
7 
PM
 Case Rep Gastroenterol 2016;10:0–0 
DOI: 10.1159/000442972 
 
© 2015 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/crg 
Jensen et al.: Acute Cytomegalovirus Hepatitis in an Immunocompetent Host as a Reason for 
Upper Right Abdominal Pain 
 
 
 
 
8 
Table 2. Dosing of oral valganciclovir for the treatment of CMV infection including dose modification for 
patients with impaired renal function [8] 
   
   
 Treatment dose, mg Frequency 
   
   
Serum creatinine   
≤1.5 mg/dl 900 BID 
1.6–2.5mg/dl 450 BID 
2.6–4.0 mg/dl 450 QD 
>4.0 mg/dl 450 QOD 
Hemodialysis unknown unknown 
Peritoneal dialysis unknown unknown 
   
   
BID = Twice a day; QD = every day; QOD = every other day. 
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